Long-Term Consequences of Amyloidosis: Chronic Organ Damage and Management Introduction Amyloidosis is a rare but severe condition involving abnormal deposition […]

Renal Manifestations of Systemic Amyloidosis: A Perspective on Nephrotic Syndrome and Albuminuria Introduction Systemic amyloidosis is a family of protein

Left Ventricular Assist Device (LVAD) Therapy in Cardiac Amyloidosis: Challenges and Feasibility Introduction Cardiac amyloidosis (CA) is a serious, progressive,

Lifestyle Changes to Enhance Quality of Life for Amyloidosis Patients Introduction Amyloidosis is a multi-faceted illness resulting from the abnormal

Severe Liver Manifestations in AL Amyloidosis – Understanding Cholestatic Liver Failure Subsets Introduction Systemic primary (AL) amyloidosis is a rare

Liver Involvement in Systemic Primary (AL) Amyloidosis – Prevalence, Clinical Insights, and Implications Introduction Systemic primary amyloidosis (AL amyloidosis) is

Clinical Presentation of Liver Involvement in AL Amyloidosis – Silent Development, Minor LFT Abnormalities, and Hepatomegaly Introduction Systemic primary amyloidosis

Anticoagulation in Cardiac Amyloidosis Patients with Atrial Fibrillation: Guideline-Based Recommendations 1. Introduction Atrial fibrillation (AF) is the frequent arrhythmia in

Amiodarone for Rhythm Control in Cardiac Amyloidosis: Best Practices and Considerations 1. Introduction The atrial fibrillation (AF) and other arrhythmias

Atrial Fibrillation in Cardiac Amyloidosis: Prevalence, Risks, and Management 1. Introduction Atrial fibrillation (AF) is a frequent arrhythmia in cardiac